YU48372B - Novi derivati aminopropanola i postupak za njihovo pravljenje - Google Patents

Novi derivati aminopropanola i postupak za njihovo pravljenje

Info

Publication number
YU48372B
YU48372B YU160990A YU160990A YU48372B YU 48372 B YU48372 B YU 48372B YU 160990 A YU160990 A YU 160990A YU 160990 A YU160990 A YU 160990A YU 48372 B YU48372 B YU 48372B
Authority
YU
Yugoslavia
Prior art keywords
group
atom
hydrogen atom
independently
phenyl
Prior art date
Application number
YU160990A
Other languages
English (en)
Other versions
YU160990A (sh
Inventor
Budai
Mezei
Petocz
Hegedus
Fekete
Hoffmann
Esses
Kiszelly
Zsila
G. Gigler
Kapolnai
Original Assignee
Egis Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar filed Critical Egis Gyogyszergyar
Publication of YU160990A publication Critical patent/YU160990A/sh
Publication of YU48372B publication Critical patent/YU48372B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/20—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups being part of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

NOVI DERIVATI AMINOPROPANOLA I POSTUPAK ZA NJIHOVO PRAVLJENJE što: R i R1 svaki nezavisno su atom vodonika, atom halogena, C1-4 alkoksi ili uzeti zajedno su metilendioki grupa; R2 i R3 svaki nezavisno su atom vodonika ili uzeti zajedno predstavljaju hemijsku vezu; R4 i R5 svaki nezavisno su atom vodonika, C3-C7 cikloalkil grupa ili normalna ili račvasta, zasićena ili nezasićena C1-12 alkil grupa koja je po izboru supstituisana sa jednom ili više dialkilaminoalkil grupa koje u alkil delu sadrže 1 do 4 atoma ugljenika, dimetoksifenil ili fenil grupa, ili R4 i R5 sa susednim atomom azota grade 4- do 7-člani prsten koji po izboru sadrži atom kiseonika, sumpora ili još jedan atom azota i po izboru je supstituisan sa fenil, benzil ili C1-3 alkil grupom gde pomenuti supstituient mogu da nose hidroksi grupu, jednu ili dve metoksi grupe, atoma halogena ili trifluorometil grupe, ili R4 i R5 sa susednim atomom azota grade piperidinski prsten koji je po izboru supstituisan sa fenil ili benzil grupom i po izboru obuhvata dvogubu vezu R6 je atom vodonika ili benzoil grupa, i n je ceo broj 3-6, i njihove adicione soli sa kiselinama i kvaterni amonijum derivati. - Prijava sadrži još 3 nezavisna i 11 zavisnih zahteva.
YU160990A 1989-08-25 1990-08-23 Novi derivati aminopropanola i postupak za njihovo pravljenje YU48372B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU894401A HU212415B (en) 1989-08-25 1989-08-25 Process for producing new cyclic oxym derivatives and pharmaceutical compositions containing them as active components

Publications (2)

Publication Number Publication Date
YU160990A YU160990A (sh) 1992-12-21
YU48372B true YU48372B (sh) 1998-07-10

Family

ID=10967860

Family Applications (1)

Application Number Title Priority Date Filing Date
YU160990A YU48372B (sh) 1989-08-25 1990-08-23 Novi derivati aminopropanola i postupak za njihovo pravljenje

Country Status (24)

Country Link
US (1) US5130487A (sh)
JP (1) JPH03169841A (sh)
KR (1) KR910004547A (sh)
AT (1) AT399504B (sh)
BE (1) BE1004530A3 (sh)
BG (1) BG92749A (sh)
CA (1) CA2023957A1 (sh)
CH (1) CH681369A5 (sh)
DD (1) DD297402A5 (sh)
DE (1) DE4027052A1 (sh)
DK (1) DK203290A (sh)
ES (1) ES2021261A6 (sh)
FI (1) FI904191A0 (sh)
FR (1) FR2651227B1 (sh)
GB (1) GB2235198B (sh)
GR (1) GR1000740B (sh)
HU (1) HU212415B (sh)
IT (1) IT1243203B (sh)
NL (1) NL9001865A (sh)
PL (1) PL163028B1 (sh)
RU (1) RU2066310C1 (sh)
SE (1) SE9002727L (sh)
YU (1) YU48372B (sh)
ZA (1) ZA906744B (sh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212262B (en) * 1992-10-30 1996-04-29 Egyt Gyogyszervegyeszeti Gyar Process to prepare benz /e/ indene derivs. and the pharmaceutical compns. contg. them
HUT67314A (en) * 1993-04-09 1995-03-28 Egyt Gyogyszervegyeszeti Gyar Process for prepg. new trisubstituted cykloalkane deriv.s and pharmaceutical compn.s contg. them
HU213421B (en) * 1993-04-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar New basic ethers, pharmaceutical compns. containing the said compds. and process for prepg. them
US5597822A (en) * 1993-07-20 1997-01-28 Egis Pharmaceutical Pharmaceutical compositions for the prevention and/or treatment a gastrointestinal diseases
HU213472B (en) * 1993-07-20 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process to preparare pharmaceutical compns. with gastroprotective and anti helicobacter pylori activity
DE19722848A1 (de) * 1997-05-23 1998-11-26 Schering Ag Leukotrien-B¶4¶-Derivate, insbesondere Oximo-LTB¶4¶-Antagonisten
KR100836547B1 (ko) * 2002-01-11 2008-06-10 상꾜 가부시키가이샤 아미노 알코올 유도체 또는 포스폰산 유도체 및 이들을함유하는 의약 조성물
WO2005079788A1 (ja) 2004-02-24 2005-09-01 Sankyo Company, Limited アミノアルコール化合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
GB1493222A (en) * 1976-01-27 1977-11-30 Egyt Gyogyszervegyeszeti Gyar Cycloalkanone oxime ethers and process for the preparation thereof
AT339276B (de) * 1976-01-27 1977-10-10 Egyt Gyogyszervegyeszeti Gyar Verfahren zur herstellung von basischen cycloalkanonoximathern und deren saureadditionssalzen
DE2658938A1 (de) * 1976-12-24 1978-07-06 Hoechst Ag Neue basisch substituierte 0-propyloxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4308399A (en) * 1977-08-30 1981-12-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
US4652586A (en) * 1980-11-07 1987-03-24 The General Hospital Corporation Selective beta-2 adrenergic antagonists for the treatment of glaucoma
FR2521856A1 (fr) * 1982-02-19 1983-08-26 Pos Lab Medicament ophtalmique pour le traitement des glaucomes, a base d'ethers-oxydes ou d'ether-oximes de derives alcoylamines
HU189227B (en) * 1983-02-08 1986-06-30 Egyt Gyogyszervegyeszeti Gyar,Hu Process for preparing basic oxime-ethers
HU189226B (en) * 1983-02-08 1986-06-30 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing basic oxime-ethers
HU197205B (en) * 1984-07-10 1989-03-28 Egyt Gyogyszervegyeszeti Gyar Process for production of medical compositions against angine
US4803286A (en) * 1987-08-19 1989-02-07 Merck & Co., Inc. Amino-2-hydroxypropyloximinoheterocycle α-blockers

Also Published As

Publication number Publication date
RU2066310C1 (ru) 1996-09-10
ES2021261A6 (es) 1991-10-16
HU212415B (en) 1996-06-28
GR1000740B (el) 1992-12-30
DE4027052C2 (sh) 1993-09-09
PL286613A1 (en) 1991-05-06
AT399504B (de) 1995-05-26
BG92749A (bg) 1993-12-24
ATA174290A (de) 1994-10-15
FI904191A0 (fi) 1990-08-24
JPH03169841A (ja) 1991-07-23
GR900100627A (en) 1991-12-30
IT9021305A0 (it) 1990-08-24
BE1004530A3 (fr) 1992-12-08
SE9002727L (sv) 1991-02-26
IT1243203B (it) 1994-05-24
NL9001865A (nl) 1991-03-18
GB2235198B (en) 1993-06-02
KR910004547A (ko) 1991-03-28
IT9021305A1 (it) 1992-02-24
DK203290D0 (da) 1990-08-24
HUT58282A (en) 1992-02-28
US5130487A (en) 1992-07-14
FR2651227A1 (fr) 1991-03-01
CA2023957A1 (en) 1991-02-26
FR2651227B1 (fr) 1992-07-31
DK203290A (da) 1991-02-26
ZA906744B (en) 1991-06-26
DE4027052A1 (de) 1991-03-07
SE9002727D0 (sv) 1990-08-24
GB2235198A (en) 1991-02-27
CH681369A5 (sh) 1993-03-15
PL163028B1 (pl) 1994-02-28
YU160990A (sh) 1992-12-21
GB9018583D0 (en) 1990-10-10
DD297402A5 (de) 1992-01-09

Similar Documents

Publication Publication Date Title
YU47554B (sh) RACEMSKI I OPTIČKI AKTIVNI DERIVATI PIRIDO (1,2-a) PIRAZINA I NJIHOVI INTERMEDIJERI
HUP9900666A2 (hu) Új fenantridinszármazékok, alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
ES8400422A1 (es) "procedimiento de preparacion de eteres triciclicos, asi como de sus sales de adicion con un acido mineral u organico terapeuticamente compatible".
YU31699A (sh) Hinolin i hinazolin jedinjenja korisna u terapiji,naročito u tretmanu benigne hiperplazije prostate
FR2663633B1 (fr) Nouvelles chalcones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CO5040088A1 (es) Nuevos compuestos y usos anestesicos locales
YU48372B (sh) Novi derivati aminopropanola i postupak za njihovo pravljenje
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
ES551988A0 (es) Procedimiento para preparar un derivado de cefalosporina.
YU48973B (sh) 3(2h)-piridazinon derivati i postupak za njihovo dobijanje
NO160783C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte beta-karbolinderivater.
ATE40554T1 (de) Furo(3,2-c>pyridinderivate, ihre herstellung und ihre therapeutische verwendung.
ES509636A0 (es) "procedimiento para preparar nuevos compuestos de aroilimidazol-2-onas".
ATE20066T1 (de) Neue basisch substituierte 4-phenyl-4,5,6,7tetrahydrothieno-(2,3-c)pyridine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES444765A1 (es) Un procedimiento para la preparacion de nuevos naftilenos.
PT782574E (pt) Carboxamidas biciclicas como antagonistas 5-ht1a
MY103521A (en) Bicyclocatechol derivatives
YU47949B (sh) 3,4-DI-(HIDRO)-2H,6H-PIRIMIDO (2,1-b)(1,3) TIAZIN DERIVATII1,2,3,4-TETRA-(HIDRO)-PIRIMIDIN.2.TIONI I POSTUPCI ZA NJIHOVO DOBIJANJE
YU179991A (sh) Racemski ili optički izohinolinski derivati
YU47562B (sh) Benzotiazinski derivati i postupak za njihovo dobijanje
YU48721B (sh) POSTUPAK ZA DOBIJANJE 1Гџ-ETIL-1α-(HIDROKSIMETIL)-1,2,3,4,6,7,12,12bα-OKTAHIDRO-INDOLO (2,3-a) HINOLIZINA I NOVIH INTERMEDIJERA
YU47017B (sh) Derivati indola, postupak za njihovo dobijanje i postupak za dobijanje farmaceutskih preparata koji ih sadrže
YU31091A (sh) Postupak za dobijanje oksetanona i intermedijeri